D ilip Shanghvi is an Indian self-made billionaire and the founder of Sun Pharmaceutical Industries, the largest pharmaceutical company in India and one of the largest generic drug manufacturers in the world. The son of a wholesale drug distributor, Shanghvi started his company in 1983 with a small investment, initially producing psychiatric drugs. He has since built it into a global pharmaceutical giant.

Shanghvi's success was driven by a two-pronged strategy of strong organic growth and a series of ambitious and highly successful acquisitions. His most transformative deal was the 2014 acquisition of his domestic rival, Ranbaxy Laboratories, for $4 billion, which catapulted Sun Pharma into a new league. He is known for his low-profile, hands-on management style and his deep expertise in the pharmaceutical industry. For a time, he surpassed Mukesh Ambani to become the richest person in India.